BetaShares Australia 200 ETF

A200

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 6966.81m in AUM and 201 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.

Black Cat Syndicate Limited

BC8

Black Cat Syndicate Ltd. engages in the business of mineral exploration and resource development. The company is headquartered in Perth, Western Australia. The company went IPO on 2018-01-30. The firm's three operations are the Paulsens Gold Operation (Paulsens), the Coyote Gold Operation (Coyote), and the Kal East Gold Project. Paulsens is located 180 km west of Paraburdoo, WA. Paulsens consists of an underground mine, a 450,000 tpa processing facility, numerous potential open pits, and other related infrastructure. Coyote is located in Northern Australia, approximately 20 kilometers (km) on the Western Australia (WA) side of the WA/Northern Territory (NT) border, on the Tanami Highway. Coyote consists of an open pit and an underground mine, a 300,000 tons per annum (tpa) processing facility, and other related infrastructure. Its Kal East Gold Project comprises approximately 1,070 square kilometers (km2) of prospective ground to the east of the mining center of Kalgoorlie, WA. The firm controls approximately 3,485 km2 in the WA gold regions.

Pharmaust Limited

PAA

PharmAust Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-10-05. The Company’s segments include Corporate and Research. The firm is focused on repurposing monepantel (MPL) for human neurodegenerative diseases. The firm's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway, that plays a central role in cell growth and proliferation of cancer cells and in degenerating neurons. The firm is also developing MPL as a treatment for motor neuron disease (MND/ALS), a rare, incurable disease. The company is focused on starting Phase II/III clinical study of MPL. The company has also completed a Phase II oncology clinical study of MPL in humans and pilot studies in canine cancer. The company is also preparing a pivotal monepantel field trial in dogs with B-Cell Lymphoma to enable product registration in the United States.

Pro Medicus Limited

PME

Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. The company is headquartered in Richmond, Victoria. The company went IPO on 2000-10-10. The firm provides a full range of medical imaging software and services to hospitals, imaging centers and health care groups in Australia, North America and Europe. Its products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a radiology information systems (RIS) medical software for practicing of management, training, installation and professional services. Visage RIS capabilities include patient registration, billing, scheduling, typing, HL7 integration, financial reporting, digital dictation and voice recognition integration. Its Visage 7.0 is a healthcare imaging software that provides clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images and picture archive and communication system (PACS)/digital imaging software that is sold directly and to original equipment manufacturers (OEM), training, installation and others.

VanEck MSCI Multifactor Em Markets Equity ETF

EMKT

EMKT.AX was created on 2018-04-10 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The VanEck MSCI Multifactor Emerging Markets Equity ETF (EMKT.AX) invests in a diversified portfolio of emerging markets listed securities with the aim of providing investment returns, before fees and other costs, which track the performance of the MSCI Emerging Markets Diversified MultipleFactor Index (AUD) (EMKT.AX Index).